CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
NeuFlex metacarpophalangeal implant +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00463424
NCT00463424Phase 2Completed
CompareCT.gov

NeuFlex and Swanson Metacarpophalangeal Implants for Rheumatoid Arthritis: a Prospective Randomized Controlled Clinical Trial

Unity Health Toronto·interventional·Posted Apr 20, 2007·Updated Apr 20, 2007

In Brief

A Phase 2 clinical trial evaluating NeuFlex metacarpophalangeal implant and Swanson metacarpophalangeal implant for Arthritis, Rheumatoid. Completed, across 1 site.

Detailed Summary

The main hypotheses for this study are as follows: 1. The use of NeuFlex implant results in flexion in the fourth and fifth MP joints that is at least 10 degrees greater than with teh use of the Swanson implant. 2. The use of the NeuFlex implant is associated with a significantly (2.5 kg or more) greater grip strength than with the use of the Swanson implant.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArthritis, Rheumatoid
CountriesCanada
CollaboratorsDePuy Orthopaedics, Stryker Trauma and Extremities

Timeline

Phase 2CompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 20, 2007
Enrollment StartOct 1, 2000
Study CompletionAug 1, 2005
TodayJul 2, 2026
Posted 19.2 years ago

Interventions

NeuFlex metacarpophalangeal implantdevice

Swanson metacarpophalangeal implantdevice